Baudax Bio, Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$1.3M

Net Income/Loss (FY2022)

-$58.8M

Total Assets (FY2022)

$10.0M

Total Equity (FY2022)

-$24.2M

Cash Flows from Operating Activities (FY2022)

-$27.8M

Source: Baudax Bio, Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.